SLC5A2 and Hyperglycemia: Vallon, V., et al. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria inproportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akitamice. American Journal of Physiology-Renal Physiology 306, F194-F204 (2014).